Literature DB >> 10385840

Behavioral and electrophysiologic predictors of treatment response to stimulants in children with attention disorders.

R J Chabot1, A A Orgill, G Crawford, M J Harris, G Serfontein.   

Abstract

Behavioral and quantitative electroencephalography (EEG) techniques were used to evaluate treatment response to stimulant therapy in children with attention disorders. A sample of 130 children with attention disorders were evaluated with Conners and Diagnostic and Statistical Manual of Mental Disorders--III rating scales, and with neurometric quantitative EEG before and 6 to 14 months after treatment with stimulants. Significant quantitative EEG differences were found between the normal control population (N = 31) and the children with attention problems. Quantitative EEG abnormalities involved increased theta or alpha power, greatest in frontal regions, frontal theta/alpha hypercoherence, and posterior interhemispheric power asymmetry. Behavioral improvement after stimulant treatment was seen in 81.5% of the children with attention-deficit hyperactivity disorder and 44.7% of the children with attention-deficit disorder, with the degree of correspondence between behavioral and quantitative EEG changes at 78.5%. Pretreatment clinical and quantitative EEG features could predict treatment response with a sensitivity of 83.1% and a specificity of 88.2%. A combined behavioral and quantitative EEG approach can be useful for following and predicting treatment response to stimulants in children with attention disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385840     DOI: 10.1177/088307389901400601

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  17 in total

1.  Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial.

Authors:  Heather M Conklin; Susan Helton; Jason Ashford; Raymond K Mulhern; Wilburn E Reddick; Ronald Brown; Melanie Bonner; Bruce W Jasper; Shengjie Wu; Xiaoping Xiong; Raja B Khan
Journal:  J Pediatr Psychol       Date:  2009-05-22

Review 2.  Quantitative electroencephalography and attention-deficit/hyperactivity disorder: implications for clinical practice.

Authors:  Vincent J Monastra
Journal:  Curr Psychiatry Rep       Date:  2008-10       Impact factor: 5.285

3.  Neurofeedback in ADHD: a single-blind randomized controlled trial.

Authors:  Ali Reza Bakhshayesh; Sylvana Hänsch; Anne Wyschkon; Mohammad Javad Rezai; Günter Esser
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-08-13       Impact factor: 4.785

Review 4.  Toward Precision Medicine in ADHD.

Authors:  Jan Buitelaar; Sven Bölte; Daniel Brandeis; Arthur Caye; Nina Christmann; Samuele Cortese; David Coghill; Stephen V Faraone; Barbara Franke; Markus Gleitz; Corina U Greven; Sandra Kooij; Douglas Teixeira Leffa; Nanda Rommelse; Jeffrey H Newcorn; Guilherme V Polanczyk; Luis Augusto Rohde; Emily Simonoff; Mark Stein; Benedetto Vitiello; Yanki Yazgan; Michael Roesler; Manfred Doepfner; Tobias Banaschewski
Journal:  Front Behav Neurosci       Date:  2022-07-06       Impact factor: 3.617

5.  Evaluation of the effect of methylphenidate by computed tomography, electroencephalography, neuropsychological tests, and clinical symptoms in children with attention-deficit/hyperactivity disorder: A prospective cohort study.

Authors:  Ozlem Yildiz Oc; Belma Agaoglu; Fatma Sen Berk; Sezer Komsuoglu; Isik Karakaya; Aysen Coskun
Journal:  Curr Ther Res Clin Exp       Date:  2007-11

Review 6.  Electrophysiological markers of genetic risk for attention deficit hyperactivity disorder.

Authors:  Charlotte Tye; Gráinne McLoughlin; Jonna Kuntsi; Philip Asherson
Journal:  Expert Rev Mol Med       Date:  2011-03-23       Impact factor: 5.600

7.  The effects of QEEG-informed neurofeedback in ADHD: an open-label pilot study.

Authors:  Martijn Arns; Wilhelmus Drinkenburg; J Leon Kenemans
Journal:  Appl Psychophysiol Biofeedback       Date:  2012-09

Review 8.  Target to treatment: A charge to develop biomarkers of response and tolerability in child and adolescent psychiatry.

Authors:  Stephani L Stancil; John Tumberger; Jeffrey R Strawn
Journal:  Clin Transl Sci       Date:  2022-01-10       Impact factor: 4.438

Review 9.  Attention deficit hyperactivity disorder.

Authors:  Jonna Kuntsi; Gráinne McLoughlin; Philip Asherson
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 10.  Advances in Electrophysiological Research.

Authors:  Chella Kamarajan; Bernice Porjesz
Journal:  Alcohol Res       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.